Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Payables: 2011-2019

Historic Payables for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $6.3 million.

  • EyePoint Pharmaceuticals' Payables rose 128.91% to $6.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $16.0 million, marking a year-over-year increase of 127.70%. This contributed to the annual value of $2.9 million for FY2018, which is 189.37% up from last year.
  • As of Q1 2019, EyePoint Pharmaceuticals' Payables stood at $6.3 million, which was up 139.32% from $2.6 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Payables high stood at $6.3 million for Q1 2019, and its period low was $303,000 during Q4 2015.
  • In the last 3 years, EyePoint Pharmaceuticals' Payables had a median value of $2.6 million in 2018 and averaged $2.6 million.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Payables dropped by 29.68% in 2016 and then surged by 272.47% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Payables stood at $303,000 in 2015, then surged by 266.34% to $1.1 million in 2016, then skyrocketed by 33.60% to $1.5 million in 2017, then soared by 78.02% to $2.6 million in 2018, then spiked by 128.91% to $6.3 million in 2019.
  • Its Payables stands at $6.3 million for Q1 2019, versus $2.6 million for Q4 2018 and $4.1 million for Q3 2018.